Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 January 2025 | Story Charlene Stanley | Photo Supplied
University of the Free State - Main Gate
The THE rankings are known to guide potential students to identify the best institutions for their chosen field of study, allowing them to compare different universities based on the strength of their academic offerings in specific study fields.

The recently published Times Higher Education (THE) World University Rankings by Subject 2025 shows that the University of the Free State (UFS) is ranked among the top 1 000 global higher learning institutions in its nine evaluated subjects, with most subject areas showing improved results from those recorded in 2024. 

The annually published THE World University Rankings by Subject is a highly regarded, trusted global benchmark for academic excellence in specific disciplines. Its methodology is designed to evaluate universities by employing a range of performance indicators categorised under five core pillars, namely Teaching, Research Environment, Research Quality, Industry, and International Outlook. 

Under Teaching, factors such as reputation, student-to-staff ratio, doctorate-to-bachelor ratio, and institutional income are considered. The Research pillar focuses on aspects such as productivity, citation impact, and influence. Among the other considerations are the income generated from industry partnerships and patents, as well as the number of international students, staff, and co-authored publications.

The methodology is carefully adjusted for each subject, ensuring fairness and accuracy by considering field-specific research cultures and publication practices.

The complete list of UFS subject rankings is as follows:

Law: 301+  *
Arts and Humanities: 501-600 # 
Education Studies: 501-600  #
Psychology: 501-600  #
Life Sciences: 601-800  #
Social Sciences: 601-800 #
Medical and Health: 801-1 000  #

Physical Sciences: 801-1 000 #

*The “+” label indicates that there is no upper limit and is used in instances where the THE does not provide exact ranks for universities beyond this position, therefore grouping institutions together to avoid overly fine distinctions at lower ranking tiers. (Eg. 801+ indicates 801st or lower.)

# The range label (eg. 801-1000), indicates that a university is ranked somewhere within this narrower range, (eg. between 801st  and 1000th. )

For more detail, visit: www.timeshighereducation.com

The THE rankings are known to guide potential students to identify the best institutions for their chosen field of study, allowing them to compare different universities based on the strength of their academic offerings in specific study fields. It also often paves the way for research collaboration, as companies are more likely to partner with highly ranked institutions in a specific sector for research and development projects. Furthermore, strong subject rankings enhance the international reputation of universities and enable comprehensive comparison in particular disciplines.

“This type of global benchmarking is extremely valuable in enhancing the international reputation of the UFS, enabling us to ultimately recruit and attract the most talented students and staff from our region and from across the globe. This aligns with our institutional strategy contained in Vision 130, whereby we aim to grow and extend our impact and influence locally, regionally, and globally,” says Prof Anthea Rhoda, acting UFS Vice-Chancellor and Principal. “Valuable knowledge and insights are also garnered during each evaluation process, allowing us to remain a globally competitive force in higher education, and to take the UFS to even greater heights in the years to come.”

Click to view document Click to view UFS Times Higher Subject Scores

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept